Aggressive prostate cancer eradicated in mice by innate and adaptive immunotherapy
They triggered an immune response that led to tumor clearance
Stay updated with breaking news from Genitourinary Oncology Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
They triggered an immune response that led to tumor clearance
Joaquim Bellmunt, MD, PhD, discusses how the FDA approval of enfortumab vedotin plus pembrolizumab impacts the urothelial cancer treatment paradigm.
The Odessa American is the leading source of local news, information, entertainment and sports for the Permian Basin.
Neeraj Agarwal, MD, FASCO, discusses unmet needs across the prostate cancer spectrum and ongoing trials investigating agents in earlier settings.
Neeraj Agarwal, FASCO, MD, discusses quality of life considerations for patients with prostate cancer.